This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2019.
Company Filing History:
1 out of 834,411 Years Active: 2019
Title: Innovations of Ravi Wijesundera in Cancer Treatment
Introduction
Ravi Wijesundera is a notable inventor based in Maharagama, Sri Lanka. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of cancer. His innovative work focuses on isolating natural compounds from local resources to develop effective treatments.
Latest Patents
Ravi Wijesundera holds a patent for a method to isolate inoscavin A from a Sri Lankan mushroom. This compound has shown promise in treating rhabdomyosarcoma, a type of cancer. The patent details a novel extraction method that includes sonication extraction, liquid-liquid partitioning, and purification through high-performance liquid chromatography (HPLC). The resulting flavonoid compound, inoscavin A, has demonstrated strong cytotoxic effects on human rhabdomyosarcoma cells, indicating its potential as a therapeutic agent.
Career Highlights
Throughout his career, Wijesundera has focused on harnessing the medicinal properties of natural products. His research has led to the development of a method that not only isolates inoscavin A but also prepares it for medicinal use. This work highlights his commitment to advancing cancer treatment through innovative approaches.
Collaborations
Ravi Wijesundera has collaborated with colleagues such as Dilusha Fernando and Preethi Soysa. Their combined efforts have contributed to the successful isolation and application of inoscavin A in cancer treatment.
Conclusion
Ravi Wijesundera's innovative work in isolating inoscavin A represents a significant advancement in the field of cancer treatment. His dedication to utilizing natural resources for medicinal purposes showcases the potential of local flora in developing effective therapies.